Results 191 to 200 of about 177,184 (344)

From the heroine of labor to the mother-heroine [PDF]

3rd International e-Conference on Studies in Humanities and Social Sciences: Conference Proceedings, 2019
openaire   +1 more source

The landscape of ketamine use disorder: Patient experiences and perspectives on current treatment options

Addiction, Volume 120, Issue 10, Page 1970-1979, October 2025.
Abstract Aims To report the symptoms and aetiology of ketamine use disorder (KUD), gauge the effectiveness of current treatment services and identify strategies to enhance patient access and outcomes. Design Mixed‐methods, cross‐sectional questionnaire. Electronic survey from November 2023 to April 2024.
Rebecca E. Harding, Tamsin Barton, Maeve Niepceron, Ella Harris, Emily Bennett, Emily Gent, Flora Fraser, Celia J. A. Morgan   +7 more
wiley   +1 more source

Skin Microbiome alterations in heroin users revealed by full-length 16S rRNA sequencing. [PDF]

BMC Microbiol
Tao R, Wang X, Zhen X, Xia R, Chen K, Zhang H, Deng Y, Zhang S.   +7 more
europepmc   +1 more source

Systemic candidiasis in heroin addicts. [PDF]

, 1986
Roderick J. Hay
openalex   +1 more source

Should heroin be prescribed to heroin misusers? Yes [PDF]

BMJ, 2008
Rehm, Jürgen, Fischer, B
openaire   +3 more sources

An age–period–cohort–interaction analysis of meth/amphetamine‐related deaths in Australia, 2001–2020

Addiction, Volume 120, Issue 10, Page 2032-2043, October 2025.
Abstract Background and Aims The number of meth/amphetamine related deaths in Australia has quadrupled in the last 20 years, primarily due to drug toxicity and suicide among individuals in their 30s and 40s. Previous analysis of Australian meth/amphetamine‐related deaths covered limited timeframes and causes, and there has been no exploration of the ...
Oisin Stronach, Paul Dietze, Michael Livingston, Amanda Roxburgh   +3 more
wiley   +1 more source

The impact of heroin abuse on a regional end-stage renal disease program. [PDF]

, 1980
M Zielezny, Eugene Cunningham, Rocco C. Venuto   +2 more
openalex   +1 more source

Extended‐release buprenorphine treatment for opioid use disorder: A mixed‐methods study of response and experience

Addiction, Volume 120, Issue 10, Page 2055-2066, October 2025.
Abstract Background and aims An investigation of 24 weeks of extended‐release buprenorphine (BUP‐XR; Sublocade®) treatment for adults with opioid use disorder (OUD). Study aims were to characterise variations in clinical response, investigate personal factors influencing BUP‐XR experience and identify opportunities to tailor treatment interventions ...
Natalie Lowry, Andrew McKechnie, Edward Day, Eilish Gilvarry, Fiona Cowden, Rachel Evans, Rosie Locke, Robbie Murray, Rob Vanderwaal, Stacey Johnstone, Zoe Hoare, Michael Kelleher, Luke Mitcheson, John Marsden   +13 more
wiley   +1 more source

Synthetic cannabinoids in e‐cigarettes seized from English schools

Addiction, Volume 120, Issue 10, Page 1995-2004, October 2025.
Abstract Background and aims People who use synthetic cannabinoids (SCs) report debilitating side effects and withdrawal symptoms, coupled with dependence. In the UK, SC use was believed to be largely restricted to prison, where they are the most common drug and associated with nearly half of non‐natural deaths, or poly‐drug users in the community who ...
Gyles E. Cozier, Matthew Gardner, Sam Craft, Martine Skumlien, Jack Spicer, Rachael Andrews, Alexander Power, Tom Haines, Richard Bowman, Amy E. Manley, Peter Sunderland, Oliver B. Sutcliffe, Stephen M. Husbands, Lindsey Hines, Gillian Taylor, Tom P. Freeman, Jennifer Scott, Christopher R. Pudney   +17 more
wiley   +1 more source

Burden, Risk Factors, and Knowledge of Non-fatal Opioid Overdose Among Injectable Drug Users: A Cross-sectional Study. [PDF]

Indian J Psychol Med
Das S, Sen S, Mondal S, Mondal M, Khatun Y, Sarkhel S, Saha I, Mukherjee S, Bhowmik K, Sarkar S, Neogi R, Rao R, Paramanik M, Bhattacharjee M, Basu A, Bhargava S, Ganguly S, Bhattacharjee S, Saha A, Chakrabarti A.   +19 more
europepmc   +1 more source